Expression of CD4, CD8 Biomarkers in Invasive Carcinoma of Breast with Clinicopathological Correlation

被引:1
作者
Divyapriya, C. [1 ]
Kannan, Aarthi [1 ]
Raghavan, Vijayashree [1 ]
机构
[1] Chettinad Acad Res & Educ, Chettinad Hosp & Res Inst, Dept Pathol, Kelambakkam 603013, Tamil Nadu, India
关键词
Breast cancer; invasive breast cancer; CD4 and CD8 markers; clinico pathological correlation; tumour infiltrating lymphocytes; TUMOR-INFILTRATING LYMPHOCYTES; T-LYMPHOCYTES; SOLID TUMORS; CANCER; SURVIVAL; TILS;
D O I
10.9734/JPRI/2021/v33i56A33886
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Tumor infiltrating lymphocytes (TILs) are widely considered a key sign of the immune interaction between host and tumor, and potentially prognostic biomarkers of good or bad outcome in various cancers, including invasive breast cancer (IBC). Aim and Objectives: To correlate the expression of CD4, CD8 T-lymphocytes in invasive carcinoma breast with established markers of prognosis like tumour size, grade, lymph node status and molecular subtypes mainly ER, PR, Her 2Neu, Ki67 status, mainly the triple negative breast cancers(TNBC). Methodology: 58 Invasive breast carcinoma proven tissue blocks were subjected to immunohistochemistry and morphometric analysis for positive CD4, CD8 T-lymphocytes were done. Results: Triple negative breast cancer subtype shows high TILs than other pathologic subtypes. Tumor interface CD8+ cells very well correlated with the pathological higher nodal stage. Majority CD4, CD8 positive cells were populated more towards the stromal and interface of the tumor microenvironment rather thatintratumoral. Conclusion: CD4+ and CD8+ counts may be a valuable independent prognostic tool in predicting the outcome in invasive breast cancer.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 25 条
[1]   Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients [J].
Ali, H. R. ;
Provenzano, E. ;
Dawson, S-J ;
Blows, F. M. ;
Liu, B. ;
Shah, M. ;
Earl, H. M. ;
Poole, C. J. ;
Hiller, L. ;
Dunn, J. A. ;
Bowden, S. J. ;
Twelves, C. ;
Bartlett, J. M. S. ;
Mahmoud, S. M. A. ;
Rakha, E. ;
Ellis, I. O. ;
Liu, S. ;
Gao, D. ;
Nielsen, T. O. ;
Pharoah, P. D. P. ;
Caldas, C. .
ANNALS OF ONCOLOGY, 2014, 25 (08) :1536-1543
[2]   Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? [J].
Badalamenti, Giuseppe ;
Fanale, Daniele ;
Incorvaia, Lorena ;
Barraco, Nadia ;
Listi, Angela ;
Maragliano, Rossella ;
Vincenzi, Bruno ;
Calo, Valentina ;
Iovanna, Juan Lucio ;
Bazan, Viviana ;
Russo, Antonio .
CELLULAR IMMUNOLOGY, 2019, 343
[3]  
Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43
[4]   Tumour-infiltrating CD4 and CD8 T lymphocytes in breast cancer [J].
Gisterek, Iwona ;
Frydecka, Irena ;
Swiatoniowski, Grzegorz ;
Fidler, Sebastian ;
Kornafel, Jan .
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2008, 13 (04) :206-209
[5]   Roles of the immune system in cancer: from tumor initiation to metastatic progression [J].
Gonzalez, Hugo ;
Hagerling, Catharina ;
Werb, Zena .
GENES & DEVELOPMENT, 2018, 32 (19-20) :1267-1284
[6]   Targeting immune cells for cancer therapy [J].
Gun, Sin Yee ;
Lee, Sharon Wei Ling ;
Sieow, Je Lin ;
Wong, Siew Cheng .
REDOX BIOLOGY, 2019, 25
[7]   Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: Relation to prognostic variables [J].
Helal, Thanaa E. A. ;
Ibrahim, Eman A. A. ;
Alloub, Amal I. A. .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (02) :89-93
[8]   Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors [J].
Hendry, Shona ;
Salgado, Roberto ;
Gevaert, Thomas ;
Russell, Prudence A. ;
John, Tom ;
Thapa, Bibhusal ;
Christie, Michael ;
van de Vijver, Koen ;
Estrada, M. V. ;
Gonzalez-Ericsson, Paula I. ;
Sanders, Melinda ;
Solomon, Benjamin ;
Solinas, Cinzia ;
Van den Eynden, Gert G. G. M. ;
Allory, Yves ;
Preusser, Matthias ;
Hainfellner, Johannes ;
Pruneri, Giancarlo ;
Vingiani, Andrea ;
Demaria, Sandra ;
Symmans, Fraser ;
Nuciforo, Paolo ;
Comerma, Laura ;
Thompson, E. A. ;
Lakhani, Sunil ;
Kim, Seong-Rim ;
Schnitt, Stuart ;
Colpaert, Cecile ;
Sotiriou, Christos ;
Scherer, Stefan J. ;
Ignatiadis, Michail ;
Badve, Sunil ;
Pierce, Robert H. ;
Viale, Giuseppe ;
Sirtaine, Nicolas ;
Penault-Llorca, Frederique ;
Sugie, Tomohagu ;
Fineberg, Susan ;
Paik, Soonmyung ;
Srinivasan, Ashok ;
Richardson, Andrea ;
Wang, Yihong ;
Chmielik, Ewa ;
Brock, Jane ;
Johnson, Douglas B. ;
Balko, Justin ;
Wienert, Stephan ;
Bossuyt, Veerle ;
Michiels, Stefan ;
Ternes, Nils .
ADVANCES IN ANATOMIC PATHOLOGY, 2017, 24 (06) :311-335
[9]   The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis [J].
Ibrahim, Ezzeldin M. ;
Al-Foheidi, Meteb E. ;
Al-Mansour, Mubarak M. ;
Kazkaz, Ghieth A. .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) :467-476
[10]   Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer [J].
Kim, Seung Tae ;
Jeong, Hoiseon ;
Woo, Ok Hee ;
Seo, Jae Hong ;
Kim, Aeree ;
Lee, Eun Sook ;
Shin, Sang Won ;
Kim, Yeul Hong ;
Kim, Jun Suk ;
Park, Kyong Hwa .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (03) :224-231